News & Events

By immersing ourselves in events and initiative, our expert teams are designed to keep you informed about the latest industry developments. Our goal is to provide essential support and tools for the success of your own groundbreaking projects.
  • / Uncategorized
Curapath and Cristal Therapeutics Partner to Advance Next-Generation Targeted Drug Delivery with CliCr® Bioconjugation Technology

At Curapath, we are committed to pushing the boundaries of polymer and lipid-based drug delivery. Today, we are excited to share that we have entered into...

Read More
Curapath renews its Crédit Impôt Recherche (CIR) accreditation for 2025
  • / Uncategorized
Curapath renews its Crédit Impôt Recherche (CIR) accreditation for 2025

Curapath is proud to announce the renewal of its Crédit Impôt Recherche (CIR)accreditation up to 2027. Granted by the French Ministry of Higher Education and Research,...

Read More
  • / Uncategorized
Curapath and Iris Biotech Partner to Provide Wider Access to Innovative Excipients for Drug Delivery

Curapath, a leading innovator in the design and manufacturing of polymer and lipid-based drug delivery systems, is proud to announce a strategic partnership with Iris Biotech,...

Read More
  • / Uncategorized
Nanothera Summit 2025 brings science and innovation to Valencia

NanoThera Summit 2025: An event that consolidates Valencia as a key hub for innovation in nanotherapies and advanced Therapies Valencia, September 2025 The inaugural edition of...

Read More
  • / Uncategorized
Curapath’s on the Move: Upcoming Conferences & Events 2025

Curapath is gearing up for a busy season of innovation, networking, and collaboration. Over the next few months, our team will be present at some of...

Read More
  • / Uncategorized
Curapath Strengthens PEG-Free Delivery Platform Through Exclusive Agreement with Calusa Bio

Curapath has entered into an exclusive license agreement with Calusa Bio, LLC, further strengthening its PEG alternative toolbox with a novel and differentiated technology. This strategic...

Read More
Proyecto cofinanciado por los Fondos FEDER, dentro del Programa Operativo FEDER de la Comunidad Valenciana 2021-2027

Desarrollo de nuevas plataformas de lípidos y su optimización en el uso de nanopartículas lipídicas para el transporte de material genético

PROGRAMA: AYUDAS PARA PROYECTOS DE I+D PYME PIDI-CV Nº Expediente: IMIDTA/2023/73

Proyecto subvencionado por el CDTI y apoyado por el Ministerio de Ciencia e Innovación

Investigación de nueva vacuna para enfermedad respiratoria humana

(VSRVAC)

PROGRAMA: Programa Misiones Empresas

Nº Expediente: EXP 00146282 / MIG-20211034

POLYPEPTIDE THERAPEUTIC SOLUTIONS, S.L. ha llevado a cabo en el año 2024 un proyecto de inversión importante en sus instalaciones con un importe subvencionado de 110.427,00 € y concedido por la Conselleria de Innovación, Industria, Comercio y Turismo a través del expediente INPYME/2024/947 dentro de la convocatoria de ayudas INPYME 2024 (Ayudas para apoyar las inversiones productivas realizadas por las PYMES de diversos sectores industriales de la Comunitat Valenciana para el ejercicio 2024 (INPYME). Industria)

Contact Us